Latest Drug delivery Stories
Microneedle Patches and Subcutaneous Implants Offer Significant Revenue Potential, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
According to new report from BCC Research, the global market RNA interference (RNAi) drug delivery technologies is expected to grow to nearly $38.8 billion by 2018, with a five-year compound annual
Revenue for fiscal year 2014 anticipated to be at the high end of the $12 million to $15 million guidance range YORK, Pa., July 30, 2014 /PRNewswire/ -- Unilife Corporation ("Unilife"
Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic, and consumer health products, today announced that Dr.
MELBOURNE, Australia, July 29, 2014 /PRNewswire/ -- -- Next phase of the TPM®/Oxymorphone clinical development program has commenced -- TPM®/Oxycodone Phase 2a trial to
LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
OMICS Group is pleased to announce the 5th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems during March 16-18, 2015 at Dubai, UAE with a theme “Exploring
LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
DALLAS, July 14, 2014 /PRNewswire-iReach/ -- ReportsnReports.com adds "Pharmaceutical Packaging Equipment Market by Package Type (Blister, Strip, Bottle, Tube, Aseptic Packaging, Wrapping,
-- Newly Issued US Patent Covers Medical Device Coating Process and Compositions -- DURHAM, N.C., July 9, 2014 /PRNewswire/ -- Micell Technologies, Inc.
- A hairdresser.